DAM
OACC

DLD Asset Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

DLD Asset Management’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.45M Buy
136,735
+1,200
+0.9% +$12.8K 0.13% 117
2025
Q4 		$1.43M Buy
135,535
+9,346
+7% +$98.9K 0.11% 125
2025
Q3 		$1.33M Buy
126,189
+26,189
+26% +$274K 0.1% 133
2025
Q2 		$1.04M Sell
100,000
-250,000
-71% -$2.59M 0.09% 121
2025
Q1 		$3.58M Buy
350,000
+175,000
+100% +$1.76M 0.28% 45
2024
Q4 		$1.74M Buy
+175,000
New +$1.75M 0.21% 53

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

DLD Asset Management's OACC Position: Q1 2026 in Review

DLD Asset Management increased its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 0.89% in Q1 2026, buying an estimated $12.8K and bringing the position to 136,735 shares worth $1.45M. The position accounts for 0.13% of the portfolio, ranked #117.

DLD Asset Management first reported a position in OACC in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.58M in Q1 2025. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • DLD Asset Management held 136,735 shares of Oaktree Acquisition Corp III Life Sciences worth $1.45M as of Q1 2026.
  • DLD Asset Management bought 1,200 Oaktree Acquisition Corp III Life Sciences shares in Q1 2026, an estimated $12.8K.
  • Oaktree Acquisition Corp III Life Sciences made up 0.13% of DLD Asset Management's portfolio in Q1 2026, its #117 holding.
  • DLD Asset Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 6 quarters since.
  • DLD Asset Management's Oaktree Acquisition Corp III Life Sciences position peaked at $3.58M in Q1 2025.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on DLD Asset Management's 13F filing for Q1 2026, filed 13 May 2026.